Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FKBP prolyl isomerase 1A pseudogene 4 (FKBP1AP4) is a member of the FKBP pseudogene family in humans. It is a nonfunctional gene segment derived from the FKBP1A (FKBP12) gene, which encodes a peptidyl-prolyl isomerase with immunophilin activity. As a pseudogene, FKBP1AP4 does not produce a protein and is presumed nonfunctional in terms of classical gene products. While some pseudogenes can modulate gene expression or be involved in regulatory RNA networks, there is currently no evidence or annotation supporting a specific biological or pathological role for FKBP1AP4. It is not considered a molecular drug target or used as a biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FKBP prolyl isomerase 1A pseudogene 4 (FKBP1AP4).